LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Brendan O’Grady, Chief Executive Officer, will participate in a fireside chat discussion as part of the Maxim Group 2024 Healthcare Virtual Summit. The fireside chat with Mr. O’Grady, hosted by Maxim Group research analyst Naz Rahman, will occur Tuesday, October 15, 2024 at 1:00 pm Eastern Time.
Investors can register to listen to the event via https://m-vest.com/events/healthcare-10152024.
About Assertio
Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.
Investor Contact
Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com
By Deepak Prakash, CTO and cofounder at Sonio The convergence of technology and healthcare has…
IRVINE, Calif.--(BUSINESS WIRE)--#respiratorycare--Nihon Kohden America, a global leader in medical technology, is proud to announce…
WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- United States Secretary of Commerce, the Honorable Gina Raimondo,…
Announces platform for professionals, advocates, and individuals to share personal recovery stories and insights MADISON,…
eHealth offers Medicare beneficiaries comprehensive support, including its new "LiveAdvise" tool, to help them enroll in…
Oakville, Ontario--(Newsfile Corp. - October 11, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)…